159 related articles for article (PubMed ID: 16308188)
1. Coated-platelets retain amyloid precursor protein on their surface.
Prodan CI; Szasz R; Vincent AS; Ross ED; Dale GL
Platelets; 2006 Feb; 17(1):56-60. PubMed ID: 16308188
[TBL] [Abstract][Full Text] [Related]
2. Rate of progression in Alzheimer's disease correlates with coated-platelet levels--a longitudinal study.
Prodan CI; Ross ED; Vincent AS; Dale GL
Transl Res; 2008 Sep; 152(3):99-102. PubMed ID: 18774538
[TBL] [Abstract][Full Text] [Related]
3. Role of mitochondrial permeability transition pore in coated-platelet formation.
Remenyi G; Szasz R; Friese P; Dale GL
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):467-71. PubMed ID: 15591217
[TBL] [Abstract][Full Text] [Related]
4. Differences in coated-platelet production between frontotemporal dementia and Alzheimer disease.
Prodan CI; Ross ED; Vincent AS; Dale GL
Alzheimer Dis Assoc Disord; 2009; 23(3):234-7. PubMed ID: 19812465
[TBL] [Abstract][Full Text] [Related]
5. Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology.
Casoli T; Di Stefano G; Giorgetti B; Grossi Y; Balietti M; Fattoretti P; Bertoni-Freddari C
Ann N Y Acad Sci; 2007 Jan; 1096():170-8. PubMed ID: 17405928
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous engagement of thrombin and Fc gamma RIIA receptors results in platelets expressing high levels of procoagulant proteins.
Batar P; Dale GL
J Lab Clin Med; 2001 Dec; 138(6):393-402. PubMed ID: 11753286
[TBL] [Abstract][Full Text] [Related]
7. Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease.
Gardella JE; Gorgone GA; Munoz PC; Ghiso J; Frangione B; Gorevic PD
Lab Invest; 1992 Sep; 67(3):303-13. PubMed ID: 1405489
[TBL] [Abstract][Full Text] [Related]
8. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms.
Borroni B; Colciaghi F; Corsini P; Akkawi N; Rozzini L; Del Zotto E; Talarico G; Cattabeni F; Lenzi GL; Di Luca M; Padovani A
Neurol Sci; 2002 Dec; 23(5):207-10. PubMed ID: 12522675
[TBL] [Abstract][Full Text] [Related]
9. Coated-platelets are higher in amnestic versus nonamnestic patients with mild cognitive impairment.
Prodan CI; Ross ED; Vincent AS; Dale GL
Alzheimer Dis Assoc Disord; 2007; 21(3):259-61. PubMed ID: 17804959
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel attenuates coated-platelet production in patients undergoing elective coronary catheterization.
Norgard NB; Saya S; Hann CL; Hennebry TA; Schechter E; Dale GL
J Cardiovasc Pharmacol; 2008 Dec; 52(6):536-9. PubMed ID: 19034031
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients.
Zimmermann M; Borroni B; Cattabeni F; Padovani A; Di Luca M
Neurobiol Dis; 2005; 19(1-2):237-42. PubMed ID: 15837579
[TBL] [Abstract][Full Text] [Related]
12. Platelets are the primary source of amyloid beta-peptide in human blood.
Chen M; Inestrosa NC; Ross GS; Fernandez HL
Biochem Biophys Res Commun; 1995 Aug; 213(1):96-103. PubMed ID: 7639768
[TBL] [Abstract][Full Text] [Related]
13. Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets.
Borroni B; Agosti C; Marcello E; Di Luca M; Padovani A
Exp Gerontol; 2010 Jan; 45(1):53-6. PubMed ID: 19699790
[TBL] [Abstract][Full Text] [Related]
14. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations.
Kempton CL; Hoffman M; Roberts HR; Monroe DM
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):861-6. PubMed ID: 15653564
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease.
Liu HC; Chi CW; Ko SY; Wang HC; Hong CJ; Lin KN; Wang PN; Liu TY
Dement Geriatr Cogn Disord; 2005; 19(5-6):345-8. PubMed ID: 15785036
[TBL] [Abstract][Full Text] [Related]
16. Presenilin-1-mediated retention of APP derivatives in early biosynthetic compartments.
Réchards M; Xia W; Oorschot V; van Dijk S; Annaert W; Selkoe DJ; Klumperman J
Traffic; 2006 Mar; 7(3):354-64. PubMed ID: 16497228
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.
Diaz-Ricart M; Palomo M; Fuste B; Lopez-Vilchez I; Carbo C; Perez-Pujol S; White JG; Escolar G
Thromb Res; 2008; 121(6):873-83. PubMed ID: 17904203
[TBL] [Abstract][Full Text] [Related]
18. Activated Alzheimer disease platelets retain more beta amyloid precursor protein.
Davies TA; Long HJ; Sgro K; Rathbun WH; McMenamin ME; Seetoo K; Tibbles H; Billingslea AM; Fine RE; Fishman JB; Levesque CA; Smith SJ; Wells JM; Simons ER
Neurobiol Aging; 1997; 18(2):147-53. PubMed ID: 9258891
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of microparticles released from coated-platelets.
Dale GL; Remenyi G; Friese P
J Thromb Haemost; 2005 Sep; 3(9):2081-8. PubMed ID: 16102115
[TBL] [Abstract][Full Text] [Related]
20. Cangrelor attenuates coated-platelet formation.
Norgard NB; Hann CL; Dale GL
Clin Appl Thromb Hemost; 2009; 15(2):177-82. PubMed ID: 18796456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
